Globalink Investment INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Globalink Investment Inc. and Alps Life Sciences Inc. have amended their merger agreement, adjusting escrow share contributions and extending the Alps Holdco shareholder consent deadline.
Globalink Investment Inc. seeks stockholder approval for a two-step business combination with Alps Life Sciences Inc., valuing Alps Holdco at $1.6 billion, despite significant PIPE investment reduction and Nasdaq delisting.
Globalink Investment Inc. is holding a special meeting to vote on proposals to extend the deadline for completing a business combination from June 9, 2025, to potentially December 9, 2025.
DEFR14A: Globalink Investment Inc. Amends Proxy Statement for Special Meeting Regarding Extension Amendment
Globalink Investment Inc. has amended its proxy statement to provide supplemental information about the proposed extension to complete a business combination, clarifying conditions and potential impacts.
Globalink Investment Inc. is seeking stockholder approval to extend the deadline for completing a business combination from December 9, 2024, to potentially June 9, 2025, along with other related proposals.